The inhibitory effect of alprazolam, a benzodiazepine, overrides the stimulatory effect of metyrapone-induced lack of negative cortisol feedback on corticotroph secretion in humans

Journal of Clinical Endocrinology and Metabolism

Volumn 84, Issue 8, 1999, Pages 2611-2615

  Arvat, Emanuela ^a   Maccagno, Barbara ^a   Ramunni, Josefina ^a   Di Vito, Lidia ^a   Giordano, Roberta ^a   Gianotti, Laura ^a   Broglio, Fabio ^a   Camanni, Franco ^a   Ghigo, Ezio ^a,b  

^a UNIVERSITY OF TURIN   (Italy)

^b MOLINETTE HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBUTYRIC ACID RECEPTOR; ALPRAZOLAM; ARGIPRESSIN; CORTICOTROPIN; CORTICOTROPIN RELEASING FACTOR; CORTODOXONE; HYDROCORTISONE; METYRAPONE;

ADULT; ARTICLE; CONTROLLED STUDY; CORTICOTROPIN BLOOD LEVEL; CORTICOTROPIN RELEASE; FEMALE; GABAERGIC SYSTEM; HORMONAL REGULATION; HUMAN; HYDROCORTISONE BLOOD LEVEL; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; NEGATIVE FEEDBACK; NORMAL HUMAN; PRIORITY JOURNAL;

EID: 0033337584     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.84.8.2611     Document Type: Article

References (40)

1. Importance of a novel GABA A receptor subunit for benzodiazepine pharmacology
2. Interaction between GABAergic neurotransmission and rat hypothalamic corticotropin-releasing hormone secretion in vitro
3. In vitro and in vivo of the triazolobenzodiazepine alprazolam on hypothalamo-pituitary-adrenal function: Pharmacological and clinical implications
4. Behavioural, biochemical and blood pressure responses to alprazolam in healthy subjects: Interactions with yohimbine
5. Neuroendocrine and monoaminergic responses to acute administration of alprazolam in normal subjects
6. Intravenous alprazolam challenge in normal subjects. Biochemical, cardiovascular, and behavioral effects
7. Alprazolam blocks the naloxone-stimulated hypothalamo-pituitary-adrenal axis in man
8. Alprazolam attenuates vasopressin-stimulated adrenocorticotropin and cortisol release: Evidence for synergy between vasopressin and corticotropin-releasing hormone in humans
9. Effects of alprazolam on pituitari-adrenal and catecholaminergic responses to metabolic sress in humans
10. The stress, but not corticotropin-releasing hormone-induced activation of the pituitary-adrenal axis in man is blocked by alprazolam
11. Reduction in urinary free cortisol during benzodiazepine treatment of panic disorder
12. Effects of dexamethasone and alprazolam, a benzodiazepine, on the stimulatory effect of hexarelin, a synthetic GHRP, on ACTH, cortisol and GH secretion in humans
13. Alprazolam in the treatment of generalized anxiety and panic disorders: A double-blind placebo-controlled study
14. Fluctuating hyper-hypocortisolaemia variant of Cushing's syndrome
15. Alprazolam. A review of its pharmacodynamic properties in the treatment of anxiety and depression
16. Effects of alprazolam, a benzodiazepine, on the ACTH and cortisol responses to hCRH, AVP and hexarelin, a synthetic GHRP, in humans
17. ACTH release in pituitary cell cultures. Effects of neurogenic peptides and neurotransmitter substances on ACTH release induced by hypothalamic corticotropin releasing factor (CRF)
18. Catecholamine receptors on locus coeruleus neurones: Pharmacological characterization
19. Anatomy and physiology of locus coeruleus neurones: Functional implication
20. Acute effects of alprazolam and adinazolam on the concentrations of corticotropin-releasing factor in the rat brain
21. Effects of alprazolam, a novel triazolobenzodiazepine, on locus coeruleus unit activity
22. Effects of various putative-neurotransmitters on the secretion of corticotrophin-releasing hormone from rat hypothalamus in vitro, a model of the neurotransmitters involved
23. Benzodiazepines attenuate the pituitary-adrenal responses to corticotrophin-releasing hormone in healthy volunteers but not in patients with Cushing's syndrome
24. Does alprazolam, in contrast to diazepam, activate α-2-adrenoceptors involved in the regulation of rat growth hormone secretion?
25. Catecholaminergic modulation of corticotropin-releasing factor and adrenocorticotropin secretion
26. Brain corticosteroid receptor balance in health and disease
27. Stress and the pituitary-adrenal axis
28. The role of the hippocampus in feedback regulation of the hypothalamic-pituitary-adrenocortical axis
29. Simplified assessment of pituitary-adrenal reserve. Measurement of serum 11-deoxycortisol and cortisol after metyrapone
30. Inhibition of adrenal steroid 11-oxygenation in the dog
31. A simplified metyrapone test with determination of plasma 11-desoxycortisol (metyrapone test with plasma S)
32. Effects of metyrapone infusion on corticotropin-releasing factor and arginine vasopressin secretion into the hypophysial portal blood of conscious, unrestrained rams
33. Assessment of stimulated and spontaneous adrenocorticotropin secretory dynamics identifies distinct components of cortisol feedback inhibition in healthy humans
34. Evidence for a delayed, integral, and proportional phase of glucocorticoid feedback on ACTH secretion in normal human volunteers
35. Effects of ovine corticotropin-releasing hormone on adrenocorticotropin secretion in the absence of glucocorticoid feedback inhibition in man
36. Continous administration of human corticotropin-releasing hormone in the absence of glucocorticoid feedback in man
37. Receptor for the age of anxiety: Pharmacology of benzodiazepine
38. GABAa/benzodiazepine receptor: Implication for the molecular basis of anxiety
39. Antidepressant and hypothalamic-pituitary-adrenocortical regulation
40. Corticotropin-releasing hormone in humans